Table 2
Baseline characteristics of the patients in whom deceleration time was measured on day 1 and of those who were excluded from the analysis
| DT measured (n=106) | DT not measured (n=25) | |
| Age (years) | 54 (9) | 58 (9)2-150 |
| Sex (F/M) | 24/82 | 12/132-150 |
| Hypertension | 41/106 | 9/25 |
| Diabetes mellitus | 16/106 | 3/25 |
| Smoking | 63/106 | 7/252-151 |
| Killip class >1 | 13/106 | 16/252-152 |
| Anterior infarct | 38/106 | 16/252-150 |
| Peak CK value | 1021 (787) | 1364 (713)2-150 |
| ESVi on day 1 (ml/m2) | 32.02 (10.29) | 43.70 (15.72)2-152 |
| EDVi on day 1 (ml/m2) | 60.14 (15.26) | 68.42 (15.76)2-151 |
| EF on day 1 (%) | 47.53 (9.82) | 37.43 (12.83)2-152 |
| WMSi on day 1 | 1.53 (0.30) | 1.87 (0.42)2-152 |
| Patent IRA | 51/94 | 7/13 |
| Multivessel CAD | 42/94 | 9/13 |
| Collaterals | 32/94 | 6/13 |
| Cardiac mortality | 14/106 | 13/252-152 |
-
Values are mean (SD) or n.
-
↵2-150 p < 0.05;
-
↵2-151 p < 0.01;
-
↵2-152 p < 0.001.
-
CAD, coronary artery disease; CK, creatine kinase; DT, early filling deceleration time; EDVi, end diastolic volume index; EF, ejection fraction; ESVi, end systolic volume index; IRA, infarct related artery; WMSi, wall motion score index.
